miR-520e
rnamiR-520e is downregulated during acute coronary syndrome and inhibits cell-proliferation pathways relevant to plaque destabilization.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleDownregulated in ACS; regulates plaque-cell proliferation and inflammation.
Also acts inCap degradation / rupture
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood or cell-free plasma
Collection tube
PAXgene/Tempus RNA tube · K2/K3-EDTA (lavender-top)
Method / principle
RT-qPCR (TaqMan) or small-RNA sequencing
Reagent / substrate
Target-specific primers/probe; reverse transcriptase (miRNA: stem-loop RT primer)
Platform
qPCR instrument / NGS
Turnaround · availability
Research / send-out · Research (few LDTs)
Literature evidence(1)
- miR-520e and its promoter region DNA methylation as potential biomarkers in atherosclerosis.Biochemistry and cell biology = Biochimie et biologie cellulaire · 2024 · PMID 38917487 · doi